History and capital write-downs are of no great interest to me. I take a lot of comfort from the acquisition announcement on August 17, which I have read quite a few times. That is the announcement of a company going forward, not that of one dwelling on the past. Guidance will be very interesting, that is for sure.
- Forums
- ASX - By Stock
- IMS
- Why
Why, page-98
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online